skip to main content
Global Search Configuration

About Alexandra

UK

28+ years of experience

Alex Shimmings_PharmaIntelligence
Alex has been covering the international pharmaceutical and biotech sectors for more than 20 years. She is currently the Executive Editor - Commercial/R&D for Scrip, Pink Sheet and In Vivo and her main work interests lie in novel drugs, and developments in pharma and biotech R&D.

Alex has held a variety of editorial positions of increasing seniority on Scrip since joining the publication as a science reporter in 1998. Currently, she heads up the European editorial team coverage of commercial and R&D developments for Scrip, Pink Sheet and In Vivo, while also writing news, analysis and features for the publications.

Over the years, Alex has covered breakthroughs in R&D in a range of therapeutic areas, including infectious diseases, cardiology and cancer, and she enjoys interviewing key industry players and opinion leaders. Alex also has a keen interest in medical history, and a degree in Biochemistry and Microbiology.

Analyst Articles

Articles by Alexandra